Clinical Trial Update: Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and preliminary efficacy of FAB117-HC in acute traumatic spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Spinal Cord Injury

Drugs mentioned

• FAB117-HC

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Acute Traumatic Spinal Cord Injury | Phase 1, Phase 2 | Status: UNKNOWN